SCHEMBL7204426

SCHEMBL7204426

CN(C)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1O[C@@H]1C(=O)Nc1ccc(C(=O)OCc2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.52
GAA P10253 1/20 0.52
RAB9A P51151 1/20 0.52
ALDH1A1 P00352 2/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
MMP9 P14780 2/20 0.45
MMP8 P22894 2/20 0.45
MMP14 P50281 1/20 0.45
CTSL P07711 2/20 0.43
CTSB P07858 2/20 0.43
CTSS P25774 2/20 0.43
CTSK P43235 2/20 0.43
KDM1A O60341 5/20 0.42
MAOA P21397 3/20 0.42
CAPN1 P07384 2/20 0.41
CYP3A4 P08684 1/20 0.41
LMNA P02545 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A3 Q01959 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7204423 1.00 KMT2A (0.52) KMT2AGAARAB9AALDH1A1MAPT
SCHEMBL7202948 0.88 MMP9 (0.50) KMT2AMMP9MMP8MMP14CAPN1
SCHEMBL7202940 0.88 MMP9 (0.50) KMT2AMMP9MMP8MMP14CAPN1
SCHEMBL7205323 0.87 MMP9 (0.55) KMT2AMMP9MMP8MMP14CAPN1
SCHEMBL7205316 0.87 MMP9 (0.55) KMT2AMMP9MMP8MMP14CAPN1
SCHEMBL7205260 0.86 MMP9 (0.50) KMT2AMMP9MMP8MMP14CAPN1
SCHEMBL7205257 0.86 MMP9 (0.50) KMT2AMMP9MMP8MMP14CAPN1
SCHEMBL7207191 0.84 F13A1 (0.56) MMP9MMP8MMP14CAPN1ITGA4
SCHEMBL7207193 0.84 F13A1 (0.56) MMP9MMP8MMP14CAPN1ITGA4
SCHEMBL5587642 0.82 MMP9 (0.63) KMT2AMMP9MMP8MMP14CAPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0921122-B1 EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL CO LTD (JP) 2003-05-21 EP disclosed
US-6110967-A USEFUL AS AGENTS FOR PREVENTING AND TREATING METABOLIC OSTEOPATHY SUCH AS OSTEOPOROSIS, HYPERCALCEMIA AND BONE METASTASIS OF CANCER BECAUSE THEY SPECIFICALLY INHIBITS CATHEPSIN L AND ITS FAMILY ENZYMES TO INHIBIT BONE RESORPTION TAIHO PHARMACEUTICALS CO., LTD. (JP) 2000-08-29 US disclosed
EP-0921122-A1 NOVEL EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1999-06-09 EP disclosed